GLP-1 Drugs Beyond Weight Loss: Ozempic’s Impact on Heart Health & Longevity (2026)
Introduction: GLP-1 Drugs Beyond Weight Loss Over the past few years, GLP-1 receptor agonists like Ozempic (semaglutide) have exploded in popularity—initially as breakthrough treatments for type 2 diabetes and later as powerful weight-loss solutions. But in 2026, science is revealing something far more transformative: these drugs may be reshaping how we treat heart disease, kidney […]
GLP-1 Drugs Beyond Weight Loss: Ozempic’s Impact on Heart Health & Longevity (2026) Read More »






